Press Releases BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Delayed Nasdaq Other stock markets 20:56:30 10/06/2024 BST			5-day change	1st Jan Change
6.66 ^USD	+3.42%		+0.60%	+2.78%

06-03	Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise	MT
06-03	BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BrainsWay Launches Prospective, Randomized, Controlled, Multicenter Trial Evaluating Accelerated Deep TMS™ for Depression	12:30pm	AQ
BrainsWay : Deep TMS™ Becomes the First and Only TMS Device Indicated for Depression Treatment in Patients Between the Ages of 68 and 86 - Form 6-K	06-03	PU
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression	06-03	AQ
BrainsWay : Corporate Presentation May 2024	05-20	PU
BrainsWay : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K	05-09	PU
BrainsWay : Immediate Report of Meeting	05-09	PU
BrainsWay Reports First Quarter 2024 Financial Results and Operational Highlights	05-08	AQ
BrainsWay to Report First Quarter 2024 Financial Results on May 8, 2024	04-24	AQ
BrainsWay Expands Deep TMS™ Access in Israel Following Significant Increase in Reimbursement Rates	04-17	AQ
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS™ to Treat Parkinson's Disease	04-04	AQ
BrainsWay : Report of Periodic or Interim Report	03-28	PU
BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis	03-28	AQ
BrainsWay : Corporate Presentation March 2024	03-18	PU
BrainsWay Broadens Partnership with Katie’s Way Plus Through Order of an Additional 18 Deep TMS™ Systems	03-18	AQ
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights	03-06	AQ
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024	02-21	AQ
BrainsWay Initiates Clinical Evaluation of Rotational Field “Deep TMS 360°™” Technology	01-10	AQ
BrainsWay Highlights Expanded Deep TMS™ Access with Growing Western U.S. Network	12-19	AQ
BrainsWay Announces Continued Expansion of Deep TMS™ in South Korea	12-07	AQ
Louisiana Insurer Expands Deep TMS™ Access for 1.9 Million Covered Lives	11-20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BrainsWay Ltd. Nasdaq

Equities

BWAY

US10501L1061

Press Releases

Filters